CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Small-molecule modulators of TRMT2A decrease PolyQ aggregation and PolyQ-induced cell death - Computational and Structural Biotechnology Journal

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

CRISPR/Cas9–mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1 - ScienceDirect

CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box

A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies - Journal of Pharmaceutical Sciences

The Pharmacokinetics and Pharmacodynamics of A Novel Recombinant Activated Human Factor VII, GEN-0828, in Hemophilia B Mice - Journal of Pharmaceutical Sciences

Synthetic Biology in Drug Discovery Leaders in Pharmaceutical Business Intelligence (LPBI) Group

PDF) Human and Mouse Artificial Chromosome Technologies for Studies of Pharmacokinetics and Toxicokinetics

Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics - ScienceDirect

PDF) Human and Mouse Artificial Chromosome Technologies for Studies of Pharmacokinetics and Toxicokinetics

Xenograft and organoid model systems in cancer research

Pharmaceutics, Free Full-Text

PDF) Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine